Breast Implants May Cause anaplastic large cell lymphoma (ALCL)


Breast implants could be linked to anaplastic large cell lymphoma (ALCL), evidence suggests

Forney is just one of the hundreds of breast-implant recipients who have developed a rare blood cancer called anaplastic large cell lymphoma (ALCL). The Food and Drug Administration has been investigating reports linking breast implants with cancer, and now has more than 400 reports about patients who developed ALCL after having a breast implant, including nine who died.


NBC Nightly News reported on its investigation that uncovered evidence breast implants “could be linked to deadly cancer that is more common than doctors and patients may realize.” According to the investigation, some women who have had implants are reporting “cancer of the immune system, linked to breast implants called ALCL, only first identified by the FDA in 2011.” The agency has “414 reported cases of ALCL and believes it has caused at least nine deaths. They have considered it rare with odds of one in 30,000 women at risk, but an NBC News investigation with the ICIJ found data from other countries suggesting the risk could be as high as one in 10,000 or even one in 1,000.”

The AP reports that starting last fall, “thousands of problems with breast implants flooded the FDA’s system. More than 4,000 injury reports filed in the last half of 2017. Another 8,000 in the first six months of 2018.” The spike in reports “came to light after the FDA instructed manufacturers in mid-2017 to go back and file individual reports in each case of patient injury, in response to a lawyer’s discovery that reports from his clients weren’t represented in the agency’s data.”

Previous articleNumber of opioids deaths in kids and teens tripled in the past 20 years
Next articleAlarming Increase in Methamphetamine Addiction
Empathic, motivated, driven and forward-thinking ECFMG Certified Medical Graduate, who combines clinical experience and knowledge with compassion to meet the new challenges. Clear awareness of diverse backgrounds, alert to widely varied patient needs and circumstances. Collaborative team player – leveraging clinical protocols while collaborating with colleagues and allied health professionals. Avid believer in “Constant & Never Ending Improvement”, hence, working enthusiastically to enhance existing clinical knowledge and improve clinical skills while fostering personal and professional development. Outstanding ability to remain calm under crisis situations, and excel in a fast pace environment. Exceptional leadership abilities, proactive in making great decisions, while prioritizing and completing tasks in a timely manner. Responsible and caring for the well-being of patients, and eager to learn while striving to serve the underserved populations.


Please enter your comment!
Please enter your name here